Traded Aug 3, 2026 · Filed Aug 4, 2026
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$16,970
Shares × reported transaction price
13 days after results of Jul 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $548.47 on Aug 3, 2026, 11% above its 52-week low and 29% below its high, after a 5% rise over the previous 30 trading days
52-week range $496.02 (Jun 29, 2026) to $768.02 (Mar 2, 2026), 19% of the way up, from 251 adjusted closes. 30 trading days earlier: $521.50 on Jun 18, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.6% | +0.3% | +3.2% |
| 30 days | -7.6% | +0.1% | -7.7% |
Past results only. Not a forecast.
120mm, advanced multi-purpose (amp) m1147 high explosive multi-purpose with tracer (hemp-t) cartridge
Starts Mar 27, 2026Runs until May 31, 2028
The Department of Defense awarded Northrop Grumman a $159M contract for advanced cartridges. This is the second largest of 10 recent contracts for the company and represents 12% of its new federal contracts this year, making it a significant but routine award after open competition.
Undefinitized contract action for common infrared countermeasure system (circm) full rate production 2 (frp2) and services year 1 delivery…
$120M committed so farcould reach $160M
Starts Jan 28, 2026Runs until Aug 31, 2028
The Department of Defense awarded Northrop Grumman a contract worth $120M so far for producing and servicing an infrared countermeasure system. This contract was awarded without competition and is expected to last about 3 years, making it a significant but planned deal for the company.
Compensation award — excluded from discretionary-purchase analysis.
